Inherited and acquired disorders of myelin: The underlying myelin pathology
Open accessThe DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Abstract
Remyelination is a major therapeutic goal in human myelin disorders, serving to restore function to demyelinated axons and providing neuroprotection. The target disorders that might be amenable to the promotion of this repair process are diverse and increasing in number. They range primarily from those of genetic, inflammatory to toxic origin. In order to apply remyelinating strategies to these disorders, it is essential to know whether the myelin damage results from a primary attack on myelin or the oligodendrocyte or both, and whether indeed these lead to myelin breakdown and demyelination. In some disorders, myelin sheath abnormalities are prominent but demyelination does not occur. This review explores the range of human and animal disorders where myelin pathology exists and focusses on defining the myelin changes in each and their cause, to help define whether they are targets for myelin repair therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis
Lennon, V. A., Wingerchuk, D. M., Kryzer, T. J., Pittock, S. J., Lucchinetti, C. F., Fujihara, K., Nakashima, I., & Weinshenker, B. G. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17551-x · Cited by 3,239 · cited 6×
“The potential viral involvement in the etiology of MS has led to considerable interest in viruses that cause demyelination as models to explore the pathophysiology of MS.”
InfluentialIgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel
Lennon, V. A., Kryzer, T. J., Pittock, S. J., Verkman, A. S., & Hinson, S. R. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050304 · Cited by 2,288 · cited 1×
“…autoantibody in NMO patients, resulted in its nosologic separation from MS. Lennon et al. (2004) first described the finding of an antibody AC C EP TE D M AN U SC R IP T (NMO-IgG) in NMO patients that was later determined to target the astrocytic water channel aquaporin-4 (Lennon et al., 2005).”
Multiple Sclerosis: An Immune or Neurodegenerative Disorder?
Trapp, B. D., & Nave, K.-A. (2008) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.30.051606.094313 · Cited by 1,724 · cited 1×
“…on OL death and inflammation and which comes first, the basic tenant that MS is an autoimmune, inflammatory disease of the CNS has been challenged and an alternative hypothesis is that it may be a neurodegenerative disorder with secondary inflammation (Stys et al., 2012; Trapp and Nave, 2008).”
Glycolytic oligodendrocytes maintain myelin and long-term axonal integrity
Fünfschilling, U., Supplie, L. M., Mahad, D., Boretius, S., Saab, A. S., Edgar, J., Brinkmann, B. G., Kassmann, C. M., Tzvetanova, I. D., Möbius, W., et al. (2012) · Nature · doi:10.1038/nature11007 · Cited by 1,523 · cited 1×
“Interestingly, conditional knockout of the Cox10 gene leading to failure of assembly of stable mitochondrial cytochrome c oxidase, resulting in peripheral neuropathy but no CNS WM changes (Funfschilling et al., 2012).”
The Immunopathology of Multiple Sclerosis: An Overview
Lassmann, H., Brück, W., & Lucchinetti, C. F. (2007) · Brain Pathology · doi:10.1111/j.1750-3639.2007.00064.x · Cited by 1,182
Myelination and support of axonal integrity by glia
Nave, K.-A. (2010) · Nature · doi:10.1038/nature09614 · Cited by 1,062
Gold, R. (2006) · Brain · doi:10.1093/brain/awl075 · Cited by 1,017 · cited 1×
“Despite the differences it has been extremely useful in helping dissect the immunopathology of MS and in the pursuit of MS therapies, and if utilized appropriately, EAE remains the closest model to MS (Denic et al., 2011; Gold et al., 2006; Ransohoff, 2012; Steinman and Zamvil, 2006).”
Matsushima, G. K., & Morell, P. (2001) · Brain Pathology · doi:10.1111/j.1750-3639.2001.tb00385.x · Cited by 984 · cited 2×
“Given its prominence as a model of demyelination and remyelination, several extensive previous (Matsushima and Morell, 2001) and more recent reviews (Gudi et al., 2014; Kipp et al., 2009) have discussed cuprizone toxicity in great detail.”
Oligodendrocytes: biology and pathology
Bradl, M., & Lassmann, H. (2010) · Acta Neuropathologica · doi:10.1007/s00401-009-0601-5 · Cited by 933 · cited 1×
“The origin of the OLs in the brain and spinal cord and their differentiation have been the subject of intense research and publication and have been reviewed in detail in this issue and elsewhere (Bradl and Lassmann, 2010; Richardson et al., 2006).”
Distinct Patterns of Multiple Sclerosis Pathology Indicates Heterogeneity in Pathogenesis
Lucchinetti, C. F., Brück, W., Rodriguez, M., & Lassmann, H. (1996) · Brain Pathology · doi:10.1111/j.1750-3639.1996.tb00854.x · Cited by 733 · cited 2×
“Actual damage to myelin sheaths in MS has been summarized by Lucchinetti et al. (1996) to be represented by four patterns, 1) Receptor-mediated phagocytosis of myelin.”
The cuprizone animal model: new insights into an old story
Kipp, M., Clarner, T., Dang, J., Copray, S., & Beyer, C. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0591-3 · Cited by 481 · cited 4×
“Finally, the mechanism of OL death in cuprizone is not fully understood (Gudi et al., 2014; Kipp et al., 2009).”
InfluentialSteinman, L., & Zamvil, S. S. (2006) · Annals of Neurology · doi:10.1002/ana.20913 · Cited by 479
Will the real multiple sclerosis please stand up?
Stys, P. K., Zamponi, G. W., van Minnen, J., & Geurts, J. J. G. (2012) · Nature Reviews Neuroscience · doi:10.1038/nrn3275 · Cited by 475
Glial response during cuprizone-induced de- and remyelination in the CNS: lessons learned
Gudi, V., Gingele, S., Skripuletz, T., & Stangel, M. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00073 · Cited by 430 · cited 3×
“Finally, the mechanism of OL death in cuprizone is not fully understood (Gudi et al., 2014; Kipp et al., 2009).”
Richardson, W. D., Kessaris, N., & Pringle, N. (2006) · Nature reviews. Neuroscience · doi:10.1038/nrn1826 · Cited by 385 · cited 1×
“The origin of the OLs in the brain and spinal cord and their differentiation have been the subject of intense research and publication and have been reviewed in detail in this issue and elsewhere (Bradl and Lassmann, 2010; Richardson et al., 2006).”
Animal models of multiple sclerosis: the good, the bad and the bottom line
Ransohoff, R. M. (2012) · Nature Neuroscience · doi:10.1038/nn.3168 · Cited by 379
Axonal loss and neuroinflammation caused by peroxisome-deficient oligodendrocytes
Kassmann, C. M., Lappe-Siefke, C., Baes, M., Brügger, B., Mildner, A., Werner, H. B., Natt, O., Michaelis, T., Prinz, M., Frahm, J., et al. (2007) · Nature Genetics · doi:10.1038/ng2070 · Cited by 357
Lipid metabolism in myelinating glial cells: lessons from human inherited disorders and mouse models
Chrast, R., Saher, G., Nave, K.-A., & Verheijen, M. H. G. (2011) · Journal of Lipid Research · doi:10.1194/jlr.r009761 · Cited by 314 · cited 5×
“Unlike myelin proteins however, there are no myelinspecific lipids (Chrast et al., 2011).”
InfluentialInflammation, demyelination, and degeneration — Recent insights from MS pathology
Stadelmann, C., Wegner, C., & Brück, W. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.07.007 · Cited by 276 · cited 3×
“This lesion classification has been the topic of much discussion (see Stadelmann et al. (2011)) since that time, particularly with regard to the homogeneity of lesions in individual patients.”
Cortical Demyelination Is Prominent in the Murine Cuprizone Model and Is Strain-Dependent
Skripuletz, T., Lindner, M., Kotsiari, A., Garde, N., Fokuhl, J., Linsmeier, F., Trebst, C., & Stangel, M. (2008) · The American Journal of Pathology · doi:10.2353/ajpath.2008.070850 · Cited by 271 · cited 1×
“Other anatomic sites can also be affected by cuprizone, such as the cerebral and cerebellar cortex (Skripuletz et al., 2010; Skripuletz et al., 2008), though definitive structural evidence of demyelination may be more difficult to identify in these sites.”
Messing, A., Brenner, M., Feany, M. B., Nedergaard, M., & Goldman, J. E. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.5384-11.2012 · Cited by 250
Olmos-Serrano, J. L., Kang, H. J., Tyler, W. A., Silbereis, J. C., Cheng, F., Zhu, Y., Pletikos, M., Jankovic-Rapan, L., Cramer, N. P., Galdzicki, Z., et al. (2016) · Neuron · doi:10.1016/j.neuron.2016.01.042 · Cited by 239 · cited 1×
“Most recently, analysis of the transcriptomes from Down‟s syndrome brains has revealed dysregulation of genes associated with OL differentiation, and hypomyelination in a trisomic mouse model (Olmos-Serrano et al., 2016).”
Pathophysiology of X-linked adrenoleukodystrophy
Berger, J., Forss-Petter, S., & Eichler, F. S. (2014) · Biochimie · doi:10.1016/j.biochi.2013.11.023 · Cited by 238 · cited 5×
“the reason for myelin breakdown is still debated (Berger et al., 2014).”
InfluentialExtensive remyelination of the CNS leads to functional recovery
Duncan, I. D., Brower, A., Kondo, Y., Curlee, J. F., & Schultz, R. D. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0812500106 · Cited by 227
Self-citationQuantifying the early stages of remyelination following cuprizone-induced demyelination
Stidworthy, M. F., Genoud, S., Suter, U., Mantei, N., & Franklin, R. J. M. (2003) · Brain Pathology · doi:10.1111/j.1750-3639.2003.tb00032.x · Cited by 224
Cloning of the human aspartoacylase cDNA and a common missense mutation in Canavan disease
Kaul, R., Ping Gao, G., Balamurugan, K., & Matalon, R. (1993) · Nature Genetics · doi:10.1038/ng1093-118 · Cited by 221 · cited 1×
“Canavan‟s disease (CD) is a rare disorder of the CNS caused by mutations in the aspartoacylase gene (ASPA) that results in accumulation of N-acetyl-aspartic acid (NAA) in the brain and in body fluids (Kaul et al., 1993).”
Blakemore, W. F. (1972) · Journal of Neurocytology · doi:10.1007/bf01102943 · Cited by 217 · cited 1×
“Blakemore (1972) described the death of OLs in the brain white matter and noted that remyelination occurred after cessation of the cuprizone diet.”
Pujol, A. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.5.499 · Cited by 214 · cited 1×
“To-date, the mouse models of ALD lack these changes though they do present with a phenotype similar to AMN as they age (Pujol et al., 2002).”
Demyelination of the superior cerebellar peduncle in the mouse induced by cuprizone
Blakemore, W. F. (1973) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(73)90118-4 · Cited by 207
Adrenomyeloneuropathy: A Neuropathologic Review Featuring Its Noninflammatory Myelopathy
Powers, J. M., DeCiero, D. P., Ito, M., Moser, A. B., & Moser, H. W. (2000) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/59.2.89 · Cited by 204
Pathophysiology of glia in perinatal white matter injury
Back, S. A., & Rosenberg, P. A. (2014) · Glia · doi:10.1002/glia.22658 · Cited by 202 · cited 1×
“Similarly in ischemic white matter stroke, OL death and myelin damage are found and in newborns who suffer from periventricular leukomalacia (Back and Rosenberg, 2014), this also occurs.”
Oligodendrocyte death results in immune-mediated CNS demyelination
Traka, M., Podojil, J. R., McCarthy, D. P., Miller, S. D., & Popko, B. (2016) · Nature Neuroscience · doi:10.1038/nn.4193 · Cited by 195 · cited 3×
“In addition, experimental induction of primary OL death in a mouse model, did not result in CNS AC C EP TE D M AN U SC R IP T inflammation (Locatelli et al., 2012).”
Mechanisms of white matter damage in multiple sclerosis
Lassmann, H. (2014) · Glia · doi:10.1002/glia.22597 · Cited by 191 · cited 3×
“MS is an inflammatory disease of the CNS and is likely to be immune mediated (Lassmann, 2014).”
Steelman, A. J., Thompson, J. P., & Li, J. (2012) · Neuroscience Research · doi:10.1016/j.neures.2011.10.002 · Cited by 183
Xie, M., Tobin, J. E., Budde, M. D., Chen, C.-I., Trinkaus, K., Cross, A. H., McDaniel, D. P., Song, S.-K., & Armstrong, R. C. (2010) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181e3de90 · Cited by 175 · cited 3×
“, 2009) and in older mice (Irvine and Blakemore, 2006), though some of this axon death may be reversible (Xie et al., 2010).”
Experimental models of virus-induced demyelination of the central nervous system
Dal Canto, M. C., & Rabinowitz, S. G. (1982) · Annals of Neurology · doi:10.1002/ana.410110202 · Cited by 173 · cited 2×
“A prevailing view derived from the epidemiology of MS is that viral exposure, early in life in those with a specific genetic background predisposes to a later autoimmune-mediated attack on the CNS (Dal Canto and Rabinowitz, 1982; Denic et al., 2011; Stohlman and Hinton, 2001).”
Chronic Oligodendrogenesis and Remyelination after Spinal Cord Injury in Mice and Rats
Hesp, Z. C., Goldstein, E. A., Miranda, C. J., Kaspar, B. K., & McTigue, D. M. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.2568-14.2015 · Cited by 164
On the biogenesis of myelin membranes: Sorting, trafficking and cell polarity
Baron, W., & Hoekstra, D. (2010) · FEBS Letters · doi:10.1016/j.febslet.2009.10.085 · Cited by 162
Myelination and Oligodendrocyte Functions in Psychiatric Diseases
Nave, K.-A., & Ehrenreich, H. (2014) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.189 · Cited by 157
Lindner, M., Fokuhl, J., Linsmeier, F., Trebst, C., & Stangel, M. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.02.004 · Cited by 136
The neurobiology of X-linked adrenoleukodystrophy, a demyelinating peroxisomal disorder
Dubois-Dalcq, M., Feigenbaum, V., & Aubourg, P. (1999) · Trends in Neurosciences · doi:10.1016/s0166-2236(98)01319-8 · Cited by 121 · cited 2×
“Pathologically, cALD is characterized by progressive demyelination of the brain, beginning in the corpus callosum with progression outward to result in confluent demyelination of the hemispheres (Fig 4B) (Dubois-Dalcq et al., 1999).”
Biochemical aspects of X-linked adrenoleukodystrophy
Kemp, S., & Wanders, R. (2010) · Brain Pathology · doi:10.1111/j.1750-3639.2010.00391.x · Cited by 116 · cited 1×
“The primary biochemical defect in ALD is the accumulation of very long-chain fatty acids (VLFCA), usually C22-26 in plasma (Kemp and Wanders, 2010).”
Papadopoulos, D., Pham-Dinh, D., & Reynolds, R. (2006) · Experimental Neurology · doi:10.1016/j.expneurol.2005.10.033 · Cited by 115
Induced pluripotent stem cell models from X-linked adrenoleukodystrophy patients
Jang, J., Kang, H., Kim, H., Kim, J. Y., Huh, Y. J., Kim, D., Yoo, J., Lee, J., Lim, B., Lee, J., et al. (2011) · Annals of Neurology · doi:10.1002/ana.22486 · Cited by 109 · cited 1×
“A potential alternative to the current mouse models is to study mutant OLs derived from fibroblasts then induced pluripotent stem cells (iPSCs) from cALD patients (Jang et al., 2011; Wang et al., 2012).”
Brain endothelial dysfunction in cerebral adrenoleukodystrophy
Musolino, P. L., Gong, Y., Snyder, J. M. T., Jimenez, S., Lok, J., Lo, E. H., Moser, A. B., Grabowski, E. F., Frosch, M. P., & Eichler, F. S. (2015) · Brain · doi:10.1093/brain/awv250 · Cited by 92 · cited 1×
“Most recently, the mechanism of BBB disruption and brain inflammation in ALD has been explored (Musolino et al., 2015).”
Non‐human primate models of multiple sclerosis
Brok, H. P. M., Bauer, J., Jonker, M., Blezer, E., Amor, S., Bontrop, R. E., Laman, J. D., & ‘t Hart, B. A. (2001) · Immunological Reviews · doi:10.1034/j.1600-065x.2001.1830114.x · Cited by 85
Traka, M., Wollmann, R. L., Cerda, S. R., Dugas, J., Barres, B. A., & Popko, B. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.1490-08.2008 · Cited by 82
Smith, C. M., Mayer, J. A., & Duncan, I. D. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.0233-13.2013 · Cited by 69 · cited 4×
“During this time, OLs accumulate multiple organelles and undergo autophagy (Smith et al., 2013b).”
InfluentialSelf-citationAblating N‐acetylaspartate prevents leukodystrophy in a Canavan disease model
Guo, F., Bannerman, P., Mills Ko, E., Miers, L., Xu, J., Burns, T., Li, S., Freeman, E., McDonough, J. A., & Pleasure, D. (2015) · Annals of Neurology · doi:10.1002/ana.24392 · Cited by 52 · cited 2×
“Gene therapy may prove to be successful (Guo et al., 2015) even if the mode of action on vacuolated myelin is not known.”
Maier, H., Wang-Eckhardt, L., Hartmann, D., Gieselmann, V., & Eckhardt, M. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.1056-15.2015 · Cited by 52
Jackson, S. J., Lee, J., Nikodemova, M., Fabry, Z., & Duncan, I. D. (2009) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/nen.0b013e3181a41d23 · Cited by 38 · cited 1×
“Indeed the progressive neurologic worsening seen after successive relapses correlates well with progressive axon loss (Hampton et al., 2008; Jackson et al., 2009).”
Self-citationWang, X.-M., Yik, W. Y., Zhang, P., Lu, W., Dranchak, P. K., Shibata, D., Steinberg, S. J., & Hacia, J. G. (2012) · Stem Cell Research & Therapy · doi:10.1186/scrt130 · Cited by 33 · cited 1×
“A potential alternative to the current mouse models is to study mutant OLs derived from fibroblasts then induced pluripotent stem cells (iPSCs) from cALD patients (Jang et al., 2011; Wang et al., 2012).”
Cited by
Oligodendrocytes in development, myelin generation and beyond
Kuhn, S., Gritti, L., Crooks, D., & Dombrowski, Y. (2019) · Cells · doi:10.3390/cells8111424 · Cited by 625
“This results in demyelination, which is characterised by destruction of the myelin sheath and death of oligodendrocytes [194] leaving axons denuded and vulnerable to neurodegeneration [1].”
BackgroundOligodendroglial Energy Metabolism and (re)Myelination
Tepavčević, V. (2021) · Life · doi:10.3390/life11030238 · Cited by 57
“Importantly, alterations of oligodendrocytes and CNS myelin are a feature of several central nervous system pathologies including leukodystrophies (genetic disorders that lead to dys/de-myelination), spinal cord injury (in which myelin loss around spared axons significantly contributes to permanent damage), multiple s…”
BackgroundGroh, J., Abdelwahab, T., Kattimani, Y., Hörner, M., Loserth, S., Gudi, V., Adalbert, R., Imdahl, F., Saliba, A.-E., Coleman, M., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-42570-2 · Cited by 39
“However, these evolutionary bene fi ts are associated with an increased vulnerability of white matter to various pathogenic processes including disease-and aging-related immune reactions 3 – 8 .”
BackgroundThe Median Eminence, A New Oligodendrogenic Niche in the Adult Mouse Brain
Zilkha-Falb, R., Kaushansky, N., & Ben-Nun, A. (2020) · Stem Cell Reports · doi:10.1016/j.stemcr.2020.04.005 · Cited by 19
Jagielska, A., Radzwill, K., Espinosa-Hoyos, D., Yang, M., Kowsari, K., Farley, J. E., Giera, S., Byrne, A., Sheng, G., Fang, N. X., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-44675-6 · Cited by 10
Metadata
- Authors
- Duncan, I. D., & Radcliff, A. B.
- Venue
- Experimental Neurology
- Publisher
- Elsevier BV
- Published
- 2016-09
- Volume
- 283
- Issue
- Pt B
- Pages
- 452-475
- ISSN
- 0014-4886 (ISSN-L)
- OpenAlex
- W2324568579
- Cited by
- 141
- References
- 52
- FWCI
- 6.78
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.